Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Depression × Interleukin-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Skin Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Depression 1

Interventions

Saline Solution 2 Escitalopram 2 Sugars 1 Interleukin-2 1 Infliximab 1 Esketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00352885 2018-09-14

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Emory University

Phase 4 Completed

20 enrolled 11 charts

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡